Morgan Stanley

Yahoo Finance • 7 hours ago

Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference

WALTHAM, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing no... Full story

Yahoo Finance • 7 hours ago

Hubbell Incorporated Completes Acquisition of DMC Power

Shelton, CT, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) (“Hubbell”) today announced that it has completed its acquisition of DMC Power, LLC (“DMC Power”) from an affiliate of Golden Gate Capital. Hubbell financed... Full story

Yahoo Finance • 8 hours ago

E*TRADE from Morgan Stanley Releases Monthly Sector Rotation Study

NEW YORK, October 01, 2025--(BUSINESS WIRE)--E*TRADE from Morgan Stanley today released the data from its monthly sector rotation study, based on the E*TRADE customer notional net percentage buy/sell behavior for stocks that comprise the S... Full story

Yahoo Finance • 8 hours ago

The Shutdown Has Created a Data Desert. Wall Street Waits for Bank Earnings to Fill in the Gaps.

Global investors are likely to find themselves in an information air pocket over the coming weeks, should both sides of the current U.S. government shutdown standoff remain entrenched, leaving markets largely unanchored heading into a cruc... Full story

Yahoo Finance • 12 hours ago

Chromatography Market in Pharmaceuticals & Biotechnology Set to Hit $19.8 Billion by 2030

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Chromatography in Pharmaceuticals and Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for chromatography in pharmaceuticals a... Full story

Yahoo Finance • 15 hours ago

Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer

Cambridge, UK, 1 October 2025 – Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel and G protein coupled receptor (GPCR)-driven diseases, today announces the appointment of Joe... Full story

Yahoo Finance • 16 hours ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative... Full story

Yahoo Finance • yesterday

Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)

Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering unique approach to CSU treatment1 Well-controlled disease observed as fast as two weeks, with demonstrated safety profile that require... Full story

Yahoo Finance • yesterday

Morgan Stanley Statement on Stress Capital Buffer Reconsideration

NEW YORK, September 30, 2025--(BUSINESS WIRE)--The Federal Reserve announced today that it has reduced Morgan Stanley’s Stress Capital Buffer (SCB) from 5.1% to 4.3%, effective on October 1, 2025 in response to the Firm seeking reconsidera... Full story

Yahoo Finance • 2 days ago

Mega Wall Street dealmakers are having their best year ever

This is turning into the year of the mega deal for Wall Street bankers. Thus far companies have announced 49 global M&A transactions valued at more than $10 billion, according to Mergermarket, the highest such count for so-called "mega de... Full story

Yahoo Finance • 2 days ago

Fertitta Entertainment Selects Amazon Business for Key Business Purchasing Needs

Fertitta Entertainment now enjoys low prices, vast selection, and a trusted experience from Amazon Business Amazon Business offers Fertitta Entertainment a global logistics network with hundreds of thousands of suppliers, streamlining pur... Full story

Yahoo Finance • 2 days ago

Breakthrough Women in Science & Medicine Episode on Brain Metastasis from Breast Cancer — Premiering on PBS, October 4

LEXINGTON, Ky., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Breakthrough Women in Science & Medicine TV series on PBS is proud to announce the October 4th premiere of an inspiring episode during Breast Cancer Awareness Month featuring Dr. Car... Full story

Yahoo Finance • 2 days ago

Novo Nordisk Stock Falls After Morgan Stanley Issues Harsh Downgrade

This article first appeared on GuruFocus. Sep 30 - Novo Nordisk's (NYSE:NVO) stock slipped more than 2.5% Tuesday after Morgan Stanley (MS) cut its rating on the Danish drugmaker to underweight from equal weight. The bank lowered its pric... Full story

Yahoo Finance • 2 days ago

Midland et SOQUEM annoncent la découverte d’une nouvelle zone de cuivre, or et ETR jusqu’à 31,60 % Cu et 6,92 g/t Au dans la Fosse du Labrador

MONTRÉAL, 30 sept. 2025 (GLOBE NEWSWIRE) -- Exploration Midland inc. (« Midland »)(TSX-V : MD) en partenariat avec SOQUEM inc. (« SOQUEM ») a le plaisir d’annoncer la découverte d’une nouvelle zone de cuivre, or et Éléments de Terres Rar... Full story

Yahoo Finance • 2 days ago

Midland and SOQUEM Announce the Discovery of A New Copper-Gold-Ree Zone Up to 31.60% Cu And 6.92 g/t Au in the Labrador Trough

MONTREAL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”)(TSX-V: MD), in partnership with SOQUEM Inc. (“SOQUEM”), is pleased to announce the discovery of a new mineralized zone with copper, gold, and rare earth el... Full story

Yahoo Finance • 2 days ago

Banking Fraud Detection & Prevention Analysis Report 2025 Featuring Accertify, ACI, ComplyAdvantage, Entrust, Feedzai, Fiserv, Hawk, LexisNexis, Mastercard, SEON, Thales, Tookitaki, TransUnion, Visa

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Fraud Detection & Prevention in Banking Market: 2025-2030" report has been added to ResearchAndMarkets.com's offering. This report serves as an essential resource for understanding the ra... Full story

Yahoo Finance • 2 days ago

Why an analyst downgrade of Wells Fargo does not change our conviction in the stock

Wells Fargo shares have more in the tank despite a downgrade from Wall Street analysts, according to Jim Cramer. The news Morgan Stanley analysts on Monday lowered their Wells Fargo rating to an equal weight hold from an overweight buy. Th... Full story

Yahoo Finance • 2 days ago

Morgan Stanley cuts Wells Fargo and U.S. Bancorp rating

Investing.com --Morgan Stanley downgraded Wells Fargo and U.S. Bancorp, saying their upside now lags peers. Though brokerage said stronger capital markets activity and expectations for six Federal Reserve rate cuts through 2026 support a... Full story

Yahoo Finance • 3 days ago

As Morgan Stanley Moves to Offer Crypto Trading, Should You Buy, Hold, or Sell MS Stock?

Once written off as a fad, cryptocurrencies [https://www.barchart.com/investing-ideas/crypto/stocks?viewName=main&orderBy=percentChange5d&orderDir=desc] have morphed into a trillion-dollar market, luring Wall Street’s biggest names. Bitcoi... Full story

Yahoo Finance • 3 days ago

Wells Fargo, U.S. Bancorp cut to Equalweight at Morgan Stanley

[Wells Fargo] ProArtWork/iStock Unreleased via Getty Images Morgan Stanley downgraded Wells Fargo (NYSE:WFC [https://seekingalpha.com/symbol/WFC]) and U.S. Bancorp (NYSE:USB [https://seekingalpha.com/symbol/USB]) to Equalweight from Overw... Full story